Papers

11

Total Citations

89

H-Index

5

About

Angelo Orsini is a pioneering urologic surgeon and researcher at the forefront of robotic-assisted surgery and artificial intelligence in oncology. His work centers on advancing minimally invasive techniques, particularly single-port and multiport robotic platforms, to treat urologic cancers with greater precision and safety. Orsini’s major contributions include demonstrating the feasibility and benefits of extraperitoneal single-port robot-assisted radical prostatectomy in frail patients, and identifying predictors of delayed discharge after robot-assisted partial nephrectomy—insights that directly improve perioperative care. His research on atypical recurrence patterns after minimally invasive surgery for urothelial carcinoma has critical implications for long-term surveillance. With over 80 citations across his most-cited papers, including a 2024 review on robotic advances garnering 39 citations, Orsini’s impact is evident. He has also explored outpatient robotic urological surgery and the integration of AI for clinical decision-making and diagnostic precision, as seen in his 2025 paper on AI in urologic oncology. His work on the Biobot system for MRI/US fusion prostate biopsy highlights his commitment to precision medicine. Orsini’s achievements position him as a key voice in the evolution of robotic urology, blending technical innovation with patient-centered outcomes.

Research Focus

Key Achievements

5
H-Index
11
Papers
89
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted surgery for the treatment of urologic cancers: recent advances
39 citations · 2024
📈 Most Prolific Year: 2024 (9 Papers)
🤝 Key Collaborators: 72
🏛 Institutions: Rush University Medical Center, University of Chieti-Pescara

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago